LabCorp

clinical laboratory company

LH NYSE ISIN US50540R4092 SEC CIK 920148 LEI 549300CDU4WF6Q2YMS76
Follow LabCorp Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $3.8B +6.9% vs same quarter last year
Net income $262.8M +0.7% vs same quarter last year
EPS, diluted $3.22 +3.2% vs same quarter last year
Operating cash flow $563.8M +45.6% vs same quarter last year
Revenue by quarter
$3.3B
$3.3B
$3.5B
$3.6B
$3.5B
$3.5B
$3.7B
$3.8B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$5B$10B$15BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$14B$877M
FY24$13B$746M
FY23$12.2B$418M
FY22$11.9B$1.3B
FY21$13.1B$2.4B
FY20$14B$1.6B
FY19$11.6B$823.8M
FY18$11.3B$883.7M
FY17$10.3B$1.2B
FY16$9.6B$711.8M
FY15$8.7B$437.6M
FY14$6B$511.2M
FY13$5.8B$573.8M
FY12$5.7B$583.1M
FY11$5.5B$519.7M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2528.8%9.9%6.3%
FY2427.9%8.4%5.7%
FY2327.7%6%3.4%
FY2231.3%12.1%10.8%
FY2138%23.2%18.1%
FY2035.4%17.5%11.1%
FY1928.1%11.5%7.1%
FY1828%11.7%7.8%
FY1730%12.7%11.9%
FY1629.9%13.3%7.5%
FY1533.4%11.5%5%
FY1436.6%15.1%8.5%
FY1338.3%17.1%9.9%
FY1239.7%18%10.3%
FY1141%17.1%9.4%
Free cash flowOperating cash flow minus capital expenditure
$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.2B
FY24$1.1B
FY23$874.1M
FY22$1.5B
FY21$2.7B
FY20$1.8B
FY19$1B
FY18$925.6M
FY17$1.2B
FY16$918.2M
FY15$726.6M
FY14$535.5M
FY13$616.5M
FY12$667.6M
FY11$709.9M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$500M$1B$1.5B$2BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$240.7M$450M
FY24$243.1M$250.1M
FY23$254M$1B
FY22$195.2M$1.1B
FY21-$1.7B
FY20-$100M
FY19-$450M
FY18-$700M
FY17-$338.1M
FY16-$43.9M
FY15-$0
FY14-$269M
FY13-$1B
FY12-$516.5M
FY11-$643.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • LabCorp
  • Healthcare median
−100%−75%−50%−25%0%25%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearLabCorpHealthcare median
FY256.3%−30.6%
FY245.7%−47%
FY233.4%−58%
FY2210.8%−80.4%
FY2118.1%−71.9%
FY2011.1%−62.2%
FY197.1%−46.3%
FY187.8%−49.6%
FY1711.9%−45.9%
FY167.5%−36%
FY155%−38.4%
FY148.5%−35.5%
FY139.9%−37.1%
FY1210.3%−29.1%
FY119.4%−27.9%